A new urine test that is about 80-92% accurate could allow for early detection of coronary artery disease. Coronary artery disease (CAD) is responsible for most of the 1.5 million heart attacks that occur in the United States each year. A cheap and simple test for biomarkers would allow for early detection and monitoring of treatment. Early detection and treatment would save lives.
Coronary artery disease (CAD) is a major cause of mortality and morbidity. Noninvasive proteome analysis could guide clinical evaluation and early/preventive treatment. Under routine clinical conditions, urine of 67 patients presenting with symptoms suspicious for CAD were analyzed by capillary electrophoresis directly coupled with mass spectrometry (CE-MS). All patients were subjected to coronary angiography and either assigned to a CAD or non-CAD group. A training set of 29 patients was used to establish CAD and non-CAD-associated proteome patterns of plasma as well as urine. Significant discriminatory power was achieved in urine but not in plasma. Therefore, urine proteomic analysis of further 38 patients was performed in a blinded study. A combination of 17 urinary polypeptides allowed separation of both groups in the test set with a sensitivity of 81%, a specificity of 92%, and an accuracy of 84%. Sequencing of urinary marker peptides identified fragments of collagen α1 (I and III), which we furthermore demonstrated to be expressed in atherosclerotic plaques of human aorta. In conclusion, specific CE-MS polypeptide patterns in urine were associated with significant CAD in patients with angina-typical symptoms. These promising findings need to be further evaluated in regard to reliability of a urine-based screening method with the potential of improving the diagnostic approaches for CAD.
In summary, in this study, a proteomic approach applied under routine clinical conditions using CE-MS in combination with a newly generated high-throughput software package supports the notion that CAD is reflected in specific polypeptide patterns in urine. Furthermore, peptides constituting these patterns can be used to identify proteins potentially important in atherosclerosis. Further studies are warranted to evaluate the potential clinical applicability of a urine-based proteome analysis for noninvasive diagnostic approaches in coronary artery disease.